## Note
nid: 1509052121893
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3), #AK_Step1_v11::#OME_banner::Clinical::12_Psychiatry::11_Catatonia, #AK_Step1_v11::#Physeo::09_Pharm::13_Psychiatric::02_Neuroleptic_Malignant_Syndrome, #AK_Step1_v11::#Physeo::09_Pharm::13_Psychiatric::16_Atypical_Antipsychotics, #AK_Step1_v11::#Pixorize::03_Pharm::01_General::D2_(Dopamine)_Receptors, #AK_Step2_v11::!FLAG_THESE_CARDS::Potential_duplicates, #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::5psych, #AK_Step2_v11::#OME::12_Psychiatry::07_Psychosis, #AK_Step2_v11::#OME::12_Psychiatry::11_Catatonia, #AK_Step2_v11::#Resources_by_rotation::Psych::uworld::dorian, #AK_Step2_v11::#Resources_by_rotation::Psych::uworld::zanki, #AK_Step2_v11::#Subjects::Psychiatry::07_Psychotic_Disorders::*Antipsychotics::*Neuroleptic_Malignant_Syndrome, #AK_Step2_v11::$AnKingUpdates::$Errata::v10-minor_text_changes, #AK_Step2_v11::Original_decks::Dorian::psych::uw, #AK_Step2_v11::Original_decks::Zanki_Step_2::Psych::UW_Psych
markdown: false

### Text
The primary cause of <b>neuroleptic malignant syndrome</b> is
<u>antagonism</u> of <b>{{c1::dopamine (D<sub>2</sub>)}}
receptors</b> in the <b>nigrostriatal pathway</b>

### Extra
<i>- Secondary to antipsychotic use</i>
<div>
  <i>- Dopamine antagonism in the nigrostriatal pathway may lead to
  diffuse "lead-pipe" rigidity seen in NMS</i>
</div>
<div>
  <div><img src="nms_1606536512074.png" class="" style=
  "height: 234px; width: 529px;"></div>
</div>
<div>
<div>
  <i><b><img class="" src="thatll%20do_1606536512074.png" style=
  "height: 253px; width: 529px;"></b></i>
</div><img class="" src="sweert_1606536512074.png" style=
"height: 465px; width: 529px;"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/psychiatry/catatonia/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_2.png"></a>
</div>

### Additional Resources


### One by one

